跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 520 条关于
“FXI”
全部
520
临床试验
351
药物
133
机构
3
资讯
33
5个月前
Waters Receives FDA 510(k) Clearance for BD BACTEC FXI Culture System, Accelerating Bloodstream Infection Diagnostics
12个月前
CRISPR Therapeutics and Sirius Therapeutics Dose First Patient in Phase 2 Trial of SRSD107 for Venous Thromboembolism Prevention
去年
Sirus Therapeutics' SRSD107 Shows Promise in Phase I siRNA Trial for Thromboembolic Disorders
9个月前
RNA Drug Pioneer RiboBio Passes Hong Kong IPO Hearing with $2B+ Partnership Portfolio
去年
CSL's Andembry (Garadacimab) Approved in Europe and UK for Hereditary Angioedema
11个月前
Bayer's Asundexian Meets Primary Endpoints in Phase III OCEANIC-STROKE Trial for Secondary Stroke Prevention
11个月前
Pharming Group to Present 12 Studies on Rare Disease Treatments at 2025 ACAAI Meeting
2年前
Xolair Receives FDA Approval for Food Allergies After Two Decades
2年前
Axi-Cel Demonstrates Survival Benefit in Elderly R/R LBCL Patients
2年前
Bridging Therapy Before Axi-Cel Doesn't Improve Outcomes in LBCL, Real-World Data Shows
第 1 页,共 4 页
上一页
下一页